Long-term treatment with sulindac in familial adenomatous polyposis: Is there an actual efficacy in prevention of rectal cancer?

Journal of Surgical Oncology

Volumn 74, Issue 1, 2000, Pages 15-20

  Tonelli, Francesco ^a   Valanzano, Rosa ^a   Messerini, Luca ^a   Ficari, Ferdinando ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Chemoprevention; Familial adenomatous polyposis; Rectal cancer; Sulindac

Indexed keywords

SULINDAC;

ADENOMATOUS POLYP; ADOLESCENT; ADULT; CANCER PREVENTION; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG EFFICACY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG TERM CARE; MALE; POLYPECTOMY; PRIORITY JOURNAL; RECTUM POLYP; SCHOOL CHILD;

ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROCTOCOLECTOMY, RESTORATIVE; RECTAL NEOPLASMS; SULINDAC;

EID: 0034041399     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9098(200005)74:1<15::AID-JSO4>3.0.CO;2-Z     Document Type: Conference Paper

References (40)

1. Bussey HJR, Eyers AA, Ritchie SM. et al.: The rectum in adenomatous polyposis: The St. Mark's policy. Br J Surg 1985;72(Suppl):S29-S31.
2. Bess MA, Adson MA, Elveback LR, et al.: Rectal cancer following colectomy for polyposis. Arch Surg 1980;115:460-467.
3. De Cosse JJ, Bulow S, Jarvinen H, et al.: Rectal cancer risk in patients treated for familial adenomatous polyposis. The Leeds Castle Polyposis Group. Br J Surg 1992;79:1372-1375.
4. Iwama T, Mishima Y, Utsumomiya J: The impact of familial adenomatous polyposis on tumorigenesis and mortality at the several organs. Ann Surg 1993;217:101-108.
5. Heiskanen I, Jarvinen HJ: Fate of the rectal stump after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Int J Colorectal Dis 1997;12:9-13.
6. Waddell WR, Loughry RW: Sulindac for polyposis of the colon. J Surg Oncol 1983;24:83-87.
7. Giardiello FM, Hamilton SR, Krush AJ, et al.: Treatment of co-Ionic and rectal adenomas with Sulindac in familial adenomatous polyposis. N Engl J Med 1993;328:1313-1316.
8. Labayle D, Fisher D, Vielh P, et al.: Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991;101:635-639.
9. Kubota O, Kino I: Minute adenomas of the depressed type in familial adenomatous polyposis of the colon. Cancer 1993;72: 1159-1164.
10. Muto T, Kamiya J, Sawada T, et al.: Small "flat adenoma" of the large bowel with special reference to its clinical pathologic features. Dis Colon Rectum 1985;28:847-851.
11. Jass JR, Sobin LH: "Histological Typing of Intestinal Tumors." Berlin: Springer-Verlag, 1989.
12. Nugent KP, Farmer KCR, Spigelman AD, et al.: Randomized controlled trial of the effect of sulindac on duodenal and rectal polyps and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 1993;80:1618-1619.
13. Gonzaga RAF, Lima FR, Carbeiro S, et al.: Sulindac treatment for familial polyposis coli. Lancet 1985;i:751.
14. Labayle C, Fischer D, Hagege JP: Efficacité du sulindac dans le traitement de la polypose rectocolique. Gastroenterol Clin Biol 1986;10:436-442.
15. Waddell WR, Ganser GF, Cerise EJ, et al.: Sulindac for polyposis of the colon. Am J Surg 1989;157:175-179.
16. Charneau J, D'Aubigny N, Burtin P, et al.: Micropolyposes rectaux après colectomie totale pour polypose familiale. Efficacité du sulindac. Gastroenterol Clin Biol 1990;14:153-157.
17. Friend WG: Sulindac suppression of colorectal polyps in Gardner's syndrome. Am Fam Physician 1990;41:891-894.
18. Iwama T, Imajo M, Mishima Y: Is sulindac effective for familial adenomatous polyposis? Abstract from the fourth biannual meeting of the Leeds Castle Polyposis Group. Int J Colorectal Dis 1991;6:235.
19. Rigau J, Piqué JM, Rubio E, et al.: Effects of long-term sulindac therapy on colonic polyposis. Ann InternMed 1991;115:952-954.
20. Winde G, Gumbinger HG, Osswald H, et al.: The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: Clinical results of a dose-finding study on rectal sulindac administration. Int J Colorectal Dis 1993;8:13-17.
21. Hamilton SR: Pathogenesis of polyps (adenoma). Dis Colon Rectum 1983;26:413-414.
22. Lynch HT, Smyrk TC, Watson P, et al.: Hereditary flat adenoma syndrome: A variant of familial adenomatous polyposis? Dis Colon Rectum 1992;35:411-421.
23. Lanspa SJ, Rouse J, Smyrk T, et al.: Epidemiologic characteristics of flat adenoma of Muto. Dis Colon Rectum 1992;35:543-546.
24. Chang WWL, Whitener CJ: Histogenesis of tubular adenomas in hereditary colonic adenomatous polyposis. Arch Pathol Lab Med 1989;113:1042-1049.
25. Wolber RA, Owen DA: Flat adenomas of the colon. Hum Pathol 1991;37:128-132.
26. Iishi H, Tatsuta M, Tsutsui S, et al. Early depressed adenocarcinoma of the large intestine. Cancer 1992;69:2406-2410.
27. Matsumoto T, Iida M, Tada S, et al.: Early detection of nonpolypoid cancers in the rectal remnant in patients with familial adenomatous polyposis/Gardner's syndrome. Cancer 1994;74:12-15.
28. Niv Y, Fraser GM: Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy. Gastroenterology 1994;107:854-857.
29. Lynch HT, Thorson AG, Smyrk T: Rectal cancer after prolonged sulindac chemoprevention. Cancer 1995;75:936-938.
30. Spagnesi MT, Tonelli F, Dolara P, et al.: Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment. Gastroenterology 1994;106:362-366.
31. Lipkin M: Biomarkers of increased susceptibility to gastrointestinal cancer: New application to studies of cancer prevention in human subjects. Cancer Res 1988;48:235-245.
32. Deschner EE, Lipkin M: Proliferative patterns in colonic mucosa in familial polyposis. Cancer 1975;35:413-418.
33. Peterson HI: Tumor angiogenesis inhibition by prostaglandin synthetase inhibitors. Anticancer Res 1988;6:251-254.
34. Haynes WL, Proia AD, Klintworth GK: Effect of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat. Invest Ophthalmol Vis Sci 1989;30:1588-1593.
35. Schnitzler M, Dwight T, Robinson BG: Sulindac increases the expression of APC mRNA in malignant colonic epithelial cells: An in vitro study. Gut 1996;38:707-713.
36. Charalambous D, O'Brien PE: Inhibition of colon cancer precursors in the rat by sulindac sulphone is not dependent on inhibition of prostaglandin synthesis. Gastroenterol Hepatol 1996;11:307-310.
37. Picariello L, Brandi ML, Formigli L, et al.: Apoptosis induced by sulindac sulfide on epithelial and mesenchymal cells from human abdominal neoplasms. Eur J Pharmacol 1998;360:105-112.
38. Piazza GA, Rahm ALK, Krutzsch M, et al.: Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res 1995;55:3110-3116.
39. Shiff SJ, Tsai L, Qiao L, et al.: The effect of sulindac on cell proliferation and cell cycle distribution of human colon cancer cells. Gastroenterology 1994;106:A440.
40. Pasricha PJ, Bedi A, O'Connor K, et al.: The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology 1995;109:994-998.